Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 127 (RPL21P127)
- Target
- RPL21P127
- Molecular classification
- Pseudogene, Other
01
Overview
Ribosomal protein L21 pseudogene 127 (RPL21P127) is a non-coding segment of DNA in the human genome and is classified as a pseudogene. It is a DNA sequence that derives from the gene encoding ribosomal protein L21 but does not produce a functional protein product. Pseudogenes like RPL21P127 are typically the result of gene duplication or retrotransposition events and accumulate mutations that prevent expression or function. While the parental gene RPL21 codes for a structural component of the ribosomal 60S subunit involved in protein synthesis, RPL21P127 has no established biological function, disease role, or direct clinical or pharmacological relevance[4][5].
- Other names
- RPL21_61_1581RPL21P127
02
Mechanism of action
None
03
Biological functions
None (pseudogenes typically do not have biological functions; the parental gene RPL21 is involved in protein synthesis, but this does not apply to the pseudogene)[4][5].
04
Disease associations
None (pseudogenes are not known to have direct disease associations; the functional gene RPL21 is associated with Hypotrichosis simplex, but that does not pertain to its pseudogenes)[4][5].
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 127 (RPL21P127).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 127 (RPL21P127).